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Changes in protein expression 
after treatment with Ancylostoma 
caninum excretory/secretory 
products in a mouse model of colitis
Javier Sotillo1,*, Ivana Ferreira1,*, Jeremy Potriquet2, Thewarach Laha3, Severine Navarro1, 
Alex Loukas1 & Jason Mulvenna2,4
Different reports have highlighted the potential use of helminths and their secretions in the treatment 
of inflammatory bowel disease (IBD) conditions; however, no reports have investigated their effects at 
a proteome level. Herein, we characterise the protein expression changes that occur in lamina propria 
(LP) and the intestinal epithelial cells (IEC) of mice with dextran sulfate sodium (DSS)-induced colitis 
treated with Ancylostoma caninum excretory/secretory (ES) products using a quantitative proteomic 
approach. We have shown how parasite products can significantly alter the expression of proteins 
involved in immune responses, cell death and with an antioxidant activity. Interestingly, significant 
changes in the expression levels of different mucins were observed in this study. MUC13, a mucin 
implicated in gastrointestinal homeostasis, was upregulated in the LP of mice with DSS-induced colitis 
treated with ES, while MUC2, a major component of mucus, was upregulated in the IEC. In addition,  
A. caninum proteins have an important effect on proteins with antioxidant functions and proteins 
involved in intestinal homeostasis and tissue integrity and regeneration. Understanding how parasites 
can ameliorate IBD pathogenesis can help us design novel treatments for autoimmune diseases.
Inflammatory bowel disease (IBD) comprises a group of conditions characterised by chronic inflammation of 
the gastrointestinal tract. Two chronic inflammatory diseases account for almost 90% of IBD cases: Crohn’s dis-
ease (CD) and ulcerative colitis (UC)1. Over recent years, the incidence of IBD has steadily increased with, at 
least, 1.4 and 2.2 million people in the United States and Europe, respectively, suffering from this disease2. The 
chronic inflammation observed in IBD is the result of an inappropriate immune response against normal intes-
tinal flora that seems to be facilitated by defects in both the barrier function of the intestinal epithelium and the 
mucosal immune system3. The resulting inflammation of the intestinal mucosa causes abdominal pain, diarrhoea, 
ulcers, bloody stools and sometimes haemorrhages or cancers4. While CD is characterised by strong mucosal and 
sub-mucosal inflammation and ulceration that can occur anywhere from the mouth to the anus, the inflamma-
tion produced by UC is limited to the colon and is associated with superficial ulceration. IBD seriously impairs 
the quality of life of sufferers and, as it is most commonly diagnosed in people between the ages of 15 and 35, it 
has severe implications for the quality of life of those afflicted. It is most prevalent in developed countries and 
more precisely in urban areas in northern climates, with the highest incidence of ulcerative colitis in the United 
States and in northern European countries2. Despite multiple studies, the reasons and conditions for onset of 
these diseases are still unknown, although there seems to be a genetic cause and an undeniable effect of environ-
mental factors and living conditions5,6.
One possible explanation for the increased prevalence of IBD in developed countries is known as the hygiene 
hypothesis7. This hypothesis suggests that the increase in autoimmune disease in developed countries is an unin-
tended consequence of the eradication of a number of formerly widespread human pathogens, including parasitic 
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worms such as hookworm. Over a long period of co-evolution the human immune system has adapted to the 
presence of these parasites and their absence can lead to the deregulation of the immune system, resulting in 
autoimmunity and associated conditions such as IBD8. The comparative absence of autoimmune disease like 
IBD and asthma in developing countries where parasite infections are still common9, adds further weight to the 
hygiene hypothesis.
As a corollary to the hygiene hypothesis, it has been suggested that helminth infection can protect against a 
range of autoimmune and/or inflammatory conditions in humans and experimental models10 and recent research 
suggests a correlation between infection with different species of helminths and a significant effect on different 
immune-mediated diseases, including IBD11,12. For example, Schistosoma mansoni infection seems to have a pro-
tective effect against anaphylaxis13, allergen-induced airway inflammation14,15 and also asthma in mice16. In pre-
liminary clinical trials, infection with the pig whipworm Trichuris suis ameliorates the symptoms and pathology 
of Crohn’s disease and ulcerative colitis in humans17,18 and infection with Ascaris lumbricoides seems to reduced 
wheezing in humans19. Furthermore, infection with the human hookworm Necator americanus has been shown 
to improve gluten tolerance in patients with celiac disease and help patients with chronic CD20,21.
Hookworms produce a complex mixture of protein and lipids, known as the excretory/secretory products 
(ES), which are released from the surface or oral opening of the parasite. ES products are a primary interface 
between the parasite and the host and, as such, are most likely to contain factors important for immunomod-
ulation in the host22. Many helminths induce immunoregulatory molecules that may assist them in evading 
host immune responses. For example, helminth infections have been shown to promote Th2 cytokines such 
as interleukin IL-4, IL-10 and transforming growth factor (TGF)-β , and may act to change the behaviour of 
pro-inflammatory immune cells such as macrophages and dendritic cells23,24. These changes could allow the par-
asite to evade the immune defences of its host but at the same time offer the host some protection from excessive 
inflammatory responses that can lead to organ damage and a decrease in the host’s life expectancy.
In this work we present a quantitative proteomics study of the protein expression changes that occur in the 
gut of mice with dextran sulfate sodium (DSS)-induced colitis. Furthermore, we examine the effects of ES from 
the model hookworm organism, Ancylostoma caninum, on protein expression in the same model. This analysis 
provides valuable information about the inflammatory pathways that are modified by parasite ES proteins and 
could lead to novel and more effective treatment for autoimmune diseases.
Results
Effect of different concentrations of A. caninum ES proteins on the intestine of mice with DSS-
induced colitis. Quantitative MS/MS analysis of proteins purified from the intestinal tissue of three bio-
logical replicates of treated and naïve mice yielded a total of 73,206 spectra representing 834 unique proteins 
(Supplementary Table 1). The effect of ES treatment on protein expression levels in the intestine of DSS-treated mice 
versus naïve (untreated control animals) was assessed by comparing the iTRAQ ratios of the identified proteins. 
After quantitative analysis, a total of 173 proteins showed significantly altered regulation after DSS or DSS+ ES 
treatment (P < 0.05) (Supplementary Table 2). The number of proteins with a significantly up- or down-regu-
lated expression, their individual expression changes and log2 fold-changes in DSS and DSS+ ES exposed groups, 
relative to the naïve controls, are shown in Fig. 1A–C. DSS had a significant (P < 0.05) effect on the expression 
of 66 proteins, and the expression level of 25 of these proteins was reversed after treatment with 10 μ g of ES 
(Supplementary Table 3, Supplementary Figure 1). Expression changes in individual proteins show a non-signif-
icant trend towards zero on the expression levels with increasing doses of A. caninum ES up to 10 μ g, after which 
there was again an increase in expression ratios after treatment with 25 μ g of ES (Fig. 1B,C). Mice given 10 μ g 
of ES also had the smallest number of proteins with significantly altered expression (156 proteins among the 3 
replicates) relative to the naïve group. In addition, 25 μ g of ES had a great effect on proteins not previously altered 
by the DSS, in comparison with 1, 5 and 10 μ g of ES (Supplementary Figure 2). 10 μ g of ES was used in further 
experiments on the LP and IEC intestinal layers.
Effect of A. caninum ES proteins on the LP of mice with DSS-induced colitis. To investigate 
the effect of A. caninum ES on the different constituents of the intestine, we isolated proteins from the LP of 
mice and performed a quantitative proteomics analysis. Samples from mice with DSS-induced colitis, treated 
and untreated with 10 μ g of A. caninum ES, were compared and naïve mice treated with PBS or same amount 
of ES were left as controls. A total of 82,356 spectra were generated and quantified (Supplementary Table 4), 
which were used to interrogate the M. musculus proteome using Mascot and X! Tandem. After validation of 
protein identifications with Scaffold, a total of 1,043 proteins were identified, from which 586 contained ≥ 2 
unique peptides. Scaffold was again used for quantification using iTRAQ reporter ions, resulting in the identifi-
cation of 152 proteins differentially expressed in the DSS and DSS+ ES group in relation to the controls (p < 0.05) 
(Supplementary Table 5). From the 152 differentially expressed proteins, 26 had been previously identified as 
significantly differentially expressed in the whole gut of mice with DSS-induced colitis after treatment with 10 μ g 
of ES (Supplementary Table 6).
The effect of A. caninum ES on intestinal proteins was visualised by plotting the log2 fold-change of proteins 
significantly dysregulated by DSS vs. DSS+ ES. Using this approach we were able to determine which proteins 
were dysregulated by DSS but returned to normal values after incubation with ES (red and green dots in Fig. 2), 
and also the proteins that were dysregulated by DSS but had a completely opposite expression after treatment 
with ES (pink and black dots in Fig. 2). Similarly, proteins that were significantly dysregulated only by ES (orange 
and blue dots in Fig. 2) were identified as proteins that could be important in the ES-mediated suppression of 
pathology in this mouse model of colitis.
Twenty-five proteins were up-regulated (orange dots) and 20 down-regulated (blue dots) only by A. can-
inum ES. Up-regulated proteins included proteins involved in cellular respiration (two different subunits of the 
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cytochrome oxidase and the NADH:ubiquinone reductase), mucins (Mucin-13), proteins involved in lipid metab-
olism (trifunctional enzyme subunit beta) and structural proteins (myosin light polypeptide 6, actin-related pro-
tein 2/3 complex subunit 2). Down-regulated proteins included oxidoreductases (peroxiredoxin-6, glutathione 
s-transferase, alcohol dehydrogenase), chaperones (heat shock protein HSP 90-alpha, heat shock protein HSP 
90-beta) and signalling proteins (14-3-3). Of the 69 proteins that were significantly dysregulated by DSS, 27 (11 
up-regulated and 16 down-regulated) returned to normal values after the treatment with A. caninum ES (red and 
green dots in Fig. 2). Proteins initially down-regulated by DSS but restored to normal expression by ES included 
proteins involved in intestine integrity such as integrin alpha-6 actin, oxidoreductases and proteins involved 
in redox homeostasis (glutathione reductase, protein disulfide-isomerase and 4-trimethylaminobutyraldehyde 
dehydrogenase).
Effect of A. caninum ES proteins on the IEC layer of mice with DSS-induced colitis. Proteins 
from the IEC layer were quantified using iTRAQ reporter ions as described above. A total of 195,996 spectra were 
obtained and quantified after MS/MS (Supplementary Table 7) and 1,567 proteins were identified (1,051 with ≥ 2 
unique peptides). Of these, 292 were identified as differentially expressed (p < 0.05) in the DSS and DSS+ ES group 
Figure 1. Effect of different doses of Ancylostoma caninum excretory/secretory (ES) proteins treatment on 
the expression of proteins. Number of proteins with a significantly changed expression (A), dot plot showing 
the expression changes of individual proteins (B) and average log2 fold-change of proteins with a significantly 
regulated expression (C).
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(Supplementary Table 8). From the 292 differentially expressed proteins, 44 had been previously identified as sig-
nificantly differentially expressed in the whole gut of mice with DSS-induced colitis after treatment with 10 μ g 
of ES (Supplementary Table 9).
To visualise protein expression changes caused by ES, protein expression ratios from the DSS+ ES and DSS 
only groups were plotted against each other as described above for the LP analysis (Fig. 3). Twenty-four pro-
teins underwent opposite regulation when the DSS and DSS+ ES groups were compared to controls: 21 were 
down-regulated in the DSS+ ES group after being up-regulated in DSS only mice (pink dots in Fig. 3), including 
junction plakoglobin and mitogen-activated protein kinase 3 (Mapk3); and 3 proteins, including calmodulin, 
were up-regulated in the DSS+ ES group after being down-regulated in DSS only mice (black dots in Fig. 3). 
One hundred and eight proteins were only observed to be dysregulated in the DSS+ ES group including pro-
teins involved in redox metabolism (alcohol dehydrogenase NADP+ , glutathione peroxidase 1, all-trans-retinol 
13,14-reductase), mucins and proteins involved in mucus secretion (calcium-activated chloride channel regulator 
1 and mucin-2), proteins related to energy metabolism (glyceraldehyde-3-phosphate dehydrogenase, sulphite 
oxidase) and proteins involved in inflammatory and immune responses (galectin-3, mitogen-activated protein 
kinase 1 (Mapk1) and others). Thirty proteins were significantly dysregulated in the DSS only group but returned 
to normal values in the DSS+ ES group (red and green dots), including proteins with an oxidoreductase activity 
such as UDP-glucose 6-dehydrogenase and Peroxiredoxin-4.
Figure 2. Scatter plot representing the log2 fold-changes of the identified proteins in the lamina propria of 
mice with DSS-induced colitis before and after treatment with Ancylostoma caninum excretory/secretory 
proteins. DSS and DSS+ ES groups were compared against naïve group.
Figure 3. Scatter plot representing the log2 fold-changes of the identified proteins in the intestinal 
epithelial cells layer of mice with DSS-induced colitis before and after treatment with Ancylostoma caninum 
excretory/secretory proteins. DSS and DSS+ ES groups were compared against naïve group.
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A. caninum ES regulates proteins related with homeostasis and immune response activity in 
the LP and IEC layer of mice with DSS-induced colitis. GO analysis was used to determine whether 
particular gene ontologies were over-represented by significantly dysregulated proteins. In proteins only dysreg-
ulated in the DSS+ ES group the most abundant GO terms within the biological process ontology were “regu-
lation of cell death”, “immune response”, “cytoskeleton organisation” and “cellular homeostasis” (Fig. 4A). With 
regards to the analysis of molecular function ontology, more than 21% and 25.2% of the proteins with a sig-
nificant regulation in the IEC layer and LP (respectively) were assigned to having an oxidoreductase activity 
(Fig. 4B). Interestingly, when we analyse the proteins upregulated and downregulated separately, the ontologies 
related with the immune system (“immune system development”, “lymphocyte coestimulation” and “immune 
response”) were abundant in proteins with a downregulated expression in the IEL. Furthermore, we found 
that the antioxidant activity dominated in proteins with a downregulated expression in both the LP and IEL 
(Supplementary Figure 3B–D); however, the term “oxidoreductase” was mostly assigned to proteins with a signif-
icant upregulation in the LP of mice. Regarding the ontologies “cell death” and “immune system development”, 
they were prominent in proteins with a downregulated expression in the LP (Supplementary Figure 3C).
Discussion
Immuno-modulatory proteins expressed by helminth parasites have great potential as therapeutics for the treat-
ment of ulcerative colitis and Crohn’s disease, two forms of IBD that affect millions of people worldwide. Different 
authors have shown that the ES products from helminths can protect mice from allergic and autoimmune 
diseases10,25. For instance, soluble extracts from the cestode Hymenolepis diminuta and the nematode Trichinella 
spiralis alleviate dinitrobenzene sulfonic acid-induced colitis in a mouse model26,27; proteins from the cyst wall of 
the cestode Echinococcus granulosus have anti-inflammatory properties and protect the integrity of the intestinal 
mucosa in mice with DSS-induced colitis28; and ES products from the hookworms Ancylostoma ceylanicum and 
A. caninum ameliorate pathology in mice with DSS-induced colitis via the down-regulation of Th1 and Th17 
responses or by inducing IL-4+ IL-10+ CD4+ T Cell responses respectively29,30.
IBD is characterised by a severe inflammation and disrupted homeostasis of the intestinal tissue after an 
abnormal activation of the mucosal immune system3. The LP and the IEC layer are the main mucosal immune 
system effectors, and failure in the balance between immunity and integrity maintenance results in mucosal 
homeostasis malfunction31–33. The IEC layer plays a key role in the defence against pathogens as it is in direct con-
tact with external agents and, in the case of parasitic infection, their ES products. Moreover, the IEC layer is also 
in intimate contact with cells from the LP and changes in cell populations and the expression of proteins in these 
tissues are of importance in protection against IBD. For instance, Smith et al.24 showed that helminth infections 
stimulate the migration of a novel macrophage population to the LP of mice with DSS-induced colitis, suppress-
ing colonic inflammation. Similarly, the suppression of inflammatory responses mechanistically associated with 
AAMФs and prostaglandins by T. crassiceps have a positive effect in the pathology of ulcerative colitis34.
Many studies have addressed the proteomic changes that occur in IBD35–39; however, no studies have analysed 
the effects that the parasite ES products have in its amelioration at a proteome level. Herein we have used a quanti-
tative high-throughput mass spectrometry approach to study the changes induced by DSS in mice and the effects 
that the A. caninum ES products have on this model of colitis. We first tested the effect of different concentrations 
of A. caninum ES in the intestine of mice with DSS-induced colitis. We found that the samples from mice given a 
10 μ g dose of ES had the smallest number of proteins significantly differentially regulated relative to the control 
group. Furthermore, the effect was consistent from 1 μ g to 10 μ g, with the 10 μ g ES sample showing the greatest 
effect. The highest protein ratios and number of proteins were found in the 25 μ g sample, suggesting that this 
concentration of ES could be damaging the intestinal epithelium. Previous studies have shown that 10 and 25 μ g 
Figure 4. Gene ontology analysis of the proteins from the lamina propria and intestinal epithelial cells 
layer of mice with DSS-induced colitis with a significantly regulated expression after treatment with 
Ancylostoma caninum excretory/secretory proteins. 
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of A. caninum ES induced a similar Th2 response in mice in the absence of DSS29, thus for our study we used 10 μ g 
of ES in order to minimize tissue damage while still getting a Th2 response.
Ferreira et al.29 found that A. caninum ES could reduce the pathology in mice with DSS-induced colitis by 
reducing the levels of proinflammatory cytokines and recruiting M2 macrophages and eosinophils. In this work 
we have found different proteins involved in immune responses involved in DSS-induced colitis and ES treat-
ment. Firstly, the expression levels of high mobility group box protein 1 (HMGB1) were significantly downreg-
ulated after treatment with A. caninum ES in both the LP and IEC layer tissues. Interestingly, this protein was 
not significantly regulated in the whole gut sample (Supplementary Table 6). This protein is secreted by different 
immune cells, including macrophages, and it is involved in inflammation and tissue damage via Toll-like recep-
tor (TLR)-4 signaling40,41. Although this protein was not elevated in the DSS only group, its down-regulation in 
the DSS+ ES group in the IEC layer might suggest an important role for this protein in inflammatory responses. 
Conversely, HMGB1 was over-expressed in the GS samples treated with 25 μ g of A. caninum ES, suggesting that 
high levels of ES counter the anti-inflammatory effects of the lower dosages, making it unsuitable for the treat-
ment of colitis in this model.
It is interesting to note that negative regulators of inflammatory responses, such as proteasome subunit alpha, 
adenosine deaminase and glutathione peroxidase 1, were also down-regulated in the IEC layer of A. caninum 
ES-treated mice. The IEC layer is composed of different types of cells such as enterocytes, goblet cells, paneth 
cells, tuft cells and intraepithelial lymphocytes, each having a specific function. The heterogeneous nature of this 
layer could make it hard to identify small effects in specific cell populations that have an important effect against 
IBD. Recently, an increase in the number of tuft cells has been associated with the Th2 responses observed after 
helminth infections42. Intraepithelial lymphocytes have been shown to play a role in homeostasis maintenance, 
although they can be highly influenced by microbial products, and could also contribute to IBD32. An integrated 
transcriptomic and proteomics analysis of these types of cells could shed more light on the specific function of 
each cell population during colitis and helminth infections.
In the present study, 54 and 29 proteins related to cell death were dysregulated in both the LP and IEC samples 
respectively, of which 11 were common to both tissues. In particular, most of the proteins assigned to “cell death” 
ontology had a downregulated ontology in both LP and IEL. The elongation factor 1, programmed cell death 
protein 6 (PDCD6) and cytochrome C were all down-regulated in the IEC layer of the DSS+ ES group when 
compared to the DSS only group. Strikingly, the expression levels of PDCD6 was upregulated in the LP of the 
DSS+ ES group while cytochrome C and elongation factor 1 were down-regulated (similar to the DSS-treated 
mice). IBD has been hypothesized to be an energy-deficient disease43, and thus down-regulation of Cytochrome 
C in both the IEC and LP is not surprising. PDCD6, originally found as a pro-apoptotic protein44, can reduce cell 
growth by inhibiting angiogenesis45. T-cell resistance against apoptosis in IBD has been suggested to be mediated 
by IL-12 and IL-646, and Ferreira et al.29 showed how A. caninum ES could reduce IL-6 levels in the intestine of 
mice with DSS-induced colitis. Thus, reduction of IL-6 levels could enhance susceptibility to T-cell apoptosis in 
the LP. In this sense, the LP could be playing an important role in the restoration of the intestinal homeostasis by 
A. caninum ES products.
The analysis of significantly dysregulated proteins showed that the A. caninum ES has an important effect 
on oxidoreductases of the LP and IEC layer. A total of 60 proteins with oxidoreductase activity were dysregu-
lated in the IEC and 38 in the LP. One of the hallmarks of IBD is oxidative stress, with reactive oxygen species 
(ROS) produced in high levels in the intestine. It is well known that macrophages generate and release ROS in 
response to different stimuli. In addition to this, M1 macrophages have been shown to activate immunopathology 
in IBD47. However, M2 macrophages play a role in protection from colitis by activating wound-healing processes 
in response to innate signals48. The extracts from different parasites (including A. caninum ES) has been shown to 
recruit M2 macrophages to the intestine of mice with induced colitis to suppress inflammation26,29. We observed 
a significant reduction in the expression of enzymes involved in glutathione metabolism in both the LP and IEC, 
in the DSS+ ES group. Reductions in the level of GSH contributes to the switch from Th1 to Th2 response, which 
influences the shift from M1 to M2 macrophages49,50. In the IEC of the DSS+ ES group the down-regulation of 
glutathione reductase, and other oxidoreductase proteins, could indicate a link between the shift from M1 to M2 
macrophages and a low level of GSH. But in the LP this protein is already down-regulated in the DSS only group 
which may indicate that a more complex mechanism is operating in this layer. In this sense, other proteins with 
an oxidoreductase activity are upregulated in the LP, which confirms that a more complex situation is observed.
We observed a significant upregulation in the expression levels of different mucins in the LP and IEC of the 
DSS+ ES group. For example, MUC13 was up-regulated in the LP of the DSS+ ES group. The role of this mucin 
is uncertain as it has been linked to inflammatory and also anti-inflammatory and anti-apoptotic effects51,52, 
although the inflammatory properties have been related to an aberrant overexpression in gastrointestinal epithe-
lial cells. However, MUC13 plays an important role in gastrointestinal homeostasis52, and it could be playing an 
important role in the regeneration of the intestinal barrier in the DSS+ ES group. In the IEC layer, elevated levels 
of MUC2 were observed; however, in the whole gut the levels of MUC2 were downregulated also after treatment 
with ES. This mucin, produced by goblet cells, is the major component of the intestinal mucus and in addition to 
maintaining the epithelial barrier, it also plays a role in enhancing homeostasis by delivering tolerogenic signals 
critical for protection against colitis53,54. Structural proteins were also up-regulated in the LP of the DSS+ ES 
group, including myosin light polypeptide 6 and actin-related protein 2/3 complex subunit 2. Conversely, in the 
DSS only group proteins involved in tissue integrity, such as integrin alpha-6, protein disulfide-isomerase and 
4-trimethylaminobutyraldehyde dehydrogenase, were down-regulated. Importantly, in the DSS+ ES group the 
expression levels of these proteins were returned to levels similar to those observed in the controls. Together, 
these data reinforce the hypothesis that A. caninum ES products are able to restore homeostasis and intestinal 
integrity during colitis.
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In the present study we present data showing the changes that occur in the intestine of mice with DSS-induced 
colitis and the effect of A. caninum ES at a proteome level. We have shown how the parasite proteins have an 
important effect on proteins with antioxidant functions or playing a role in the immune system and cell death. 
We also observed significant changes in the expression of proteins involved in intestinal homeostasis and tissue 
integrity and regeneration. Hookworm secreted proteins are being screened for their anti-inflammatory proper-
ties, so understanding the mechanisms underlying the anti-inflammatory properties of ES proteins will help in 
the identification of novel therapeutics for the treatment of autoimmune disease.
Methods
Parasite material and isolation of ES products. A. caninum adult worms were cultured and ES prod-
ucts collected as described previously29. Briefly, parasites were incubated in serum free medium containing 100 μ g 
of streptomycin/ml and 100 U of penicillin/μ l for 24 h. The supernatant (ES) was collected, filter sterilized through 
a 0.22-μ m-pore-size filter (Pall), and concentrated and buffer exchanged to PBS using a 10-kDa spin column 
(Pall). Triton X-114 (Sigma) was used to remove lipopolysaccharide (LPS) from ES as previously described29. 
Briefly, ES was incubated at 4 °C with 5% Triton X-114 for 30 min, followed by a 10 min incubation at 37 °C and a 
centrifugation at 1,600 g for 15 min at room temperature. The upper endotoxin-free phase was collected, and the 
process was repeated twice to ensure thorough removal of endotoxin. The protein concentration was calculated 
using a micro-BCA protein assay kit (Pierce), and the Limulus Amebocyte Lysate (Lonza) assay was used to con-
firm the adequate removal of endotoxin.
Animals, DSS-induced colitis and tissue collection. The protocols used for animal experimentation 
were approved by the James Cook University Animal Ethics Committee. Six to eight week old female C57BL/6 
mice were purchased from Animal Resource Center (Perth, Australia) and were housed and handled according 
to Australian animal rights and regulation standards. Mice received food and water ad libitum.
The DSS model of colitis has been previously described29. Colitis was induced by administering a 3.5% (wt/vol) 
solution of dextran sodium sulfate (DSS 36000–50000 kDa; MP Biomedicals) to mice as a substitute for nor-
mal drinking water. To determine the dose of ES that had the greatest ameliorating effect on protein expres-
sion changes observed during DSS-induced colitis, three mice (biological replicates) per experimental condition 
were analysed (Fig. 5). Four animals having DSS-induced colitis received daily intraperitoneal (i.p.) injections 
of different amounts of A. caninum ES (1, 5, 10 or 25 μg), and two groups of control animals (three mice with 
DSS-induced colitis and three healthy mice) received no ES treatment (Fig. 5). Mice were sacrificed and their 
intestine analysed at day 8 post DSS administration. For the proteomic analysis of the intestinal epithelial (IEC) 
layer and the lamina propria (LP) two replicates were performed using four groups of four mice with each group 
receiving either DSS only, ES only, DSS plus ES or neither DSS or ES (naïve group) (Fig. 5). The DSS only group 
received a mock injection of PBS instead of ES.
For the isolation of intestinal mucosa, colons were cut in 1 cm pieces and placed in a 50 ml conical tube with 
5 ml of RPMI supplemented with glutamine, 5 mM EDTA, 2% fetal calf serum (FCS) and 2 mM dithiothreitol 
(DTT) as previously described55. Briefly, samples were incubated at room temperature (RT) for 30 min under agi-
tation and filtered through a metal strainer. Tissue was collected for isolation of LP and supernatant washed with 
RPMI containing glutamine and 5 mM EDTA twice at 4 °C and finally pelleted for protein extraction. The tissue 
obtained from the previous filtration with the metal strainer was incubated in 5 ml of RPMI supplemented with 
glutamine, 5 mM EDTA, 2% fetal calf serum (FCS), 400 U type I collagenase and 1 mg/ml DNase I at 37 °C for 
30 min under gentle agitation and filtered again through a metal strainer. Supernatant was processed as described 
previously and finally pelleted for LP protein extraction. IEC and LP cells were counted and the volume was 
adjusted for a concentration of 3 × 106 cells/ml.
Protein extraction and iTRAQ labelling. Total gut samples (GS), IEC layer and LP harvested from 
the colon of euthanized mice were treated with a cell lysis buffer containing 7 M urea, 2 M thiourea, 4% Chaps 
and 1 mM of protease inhibitor (phenylmethanesulfonyl fluoride). Lysis was performed in a high-speed shaker 
(Qiagen TissueLyserII), the resulting lysate was centrifuged at 8000 g for 5 min and the supernatants were con-
centrated and buffer exchanged using 10 kDa Amicon filters (Merck Millipore) retained for further analysis. 
iTRAQ labelling, reduction, alkylation and digestion was performed according to the manufacturer’s protocol 
(AB Sciex). Briefly, 100 μ g of protein from each sample was denatured with 2% SDS, reduced with 50 mM Tris-
(2-carboxyethyl)-phosphine (TCEP) at 60 °C for 1 h, and cysteine residues were alkylated with 10 mM methyl 
methanethiosulfate (MMTS) solution at RT for 10 min. Proteins were trypsin digested at 37 °C for 16 h, and each 
sample was labelled with different iTRAQ reagents having distinct isotopic compositions. To remove the excess 
of iTRAQ labeling, a HiTrap SP HP column (GE Healthcare) was used according to the manufacturer’s instruc-
tions and desalting and cleanup of samples was performed prior to electrofocusing using a Sep-Pak C18 cartridge 
(Waters).
OFFGEL electrophoresis (OGE). A 3100 OFFGEL Fractionator (Agilent Technologies) with a 24 well 
setup was used for pI-based peptide separation as previously described56. Briefly, the 24 cm long, 3–10 linear pH 
range IPG gel strips (GE Healthcare) were rehydrated with IPG Strip Rehydration Solution for 15 min. A total of 
3.6 ml of OFFGEL peptide sample solution was used to dissolve the samples and 150 μ l was loaded in each well. 
For isoelectric focusing, a maximum current of 50 μ A was applied until 50 kVh was reached. Peptide fractions 
were harvested and each well rinsed with 150 μ l of a solution of water/methanol/formic acid (49%/50%/1%) for 
15 min. These solutions were pooled with their corresponding peptide fraction and evaporated using a vacuum 
concentrator. Desalting of samples was performed using ZipTip (Millipore) according to the manufacturer’s pro-
tocol followed by centrifugation under vacuum.
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Mass spectrometry and protein identification. Total gut OGE fractions were chromatographically sep-
arated on a Dionex Ultimate 3000 HPLC using an Agilent Zorbax 300SB-C18 (3,5 μ m, 150 mm × 75 μ m) column. 
A flow rate of 300 nl/min and a linear gradient of 0–80% Solvent B over 60 min was used. The mobile phase con-
sisted of solvent A (0,1% formic acid (aq)) and Solvent B (80/20 acetonitrile/0,1% formic acid (aq)). Eluates from 
the RP-HPLC column were directly introduced into the NanoSpray II ionisation source of a QSTAR Elite Hybrid 
MS/MS System (Applied Biosystems) operated in positive ion electrospray mode. All analyses were performed 
using Information Dependant Acquisition, and Analyst 2.0 (Applied Biosystems) was used for data analysis. IEC 
layer and LP fractions separated by OFFGEL were analyzed by LC-MS/MS on a Shimadzu Prominance Nano 
HPLC coupled to an AB SCIEX Triple Tof 5600 mass spectrometer (Applied Biosystems). Five microliters of 
sample was injected onto a C18 trap column (Agilent Technologies) and desalted for 5 min using 0.1% formic 
acid (aq) at 30 μ l/min. Peptides were then eluted onto an analytical nano HPLC column (Agilent Technologies) 
and separated using a 35 min gradient of 1–40% buffer B followed by a steeper gradient from 40–80% buffer B in 
5 min. Buffer B contained 90/10 acetonitrile/0.1% formic acid, and buffer A consisted of 0.1% formic acid (aq). 
The mass spectrometer was operated in an Information Dependent Acquisition, IDA, mode, and full scan TOFMS 
data were acquired over the mass range 350–1400 m/z and product ion scans over the mass range of 80–1400 m/z 
for up to 20 of the most abundant ions with a relative intensity above 100 and a charge state of + 2 –+ 5. 
Analyst TF 1.6.1 software (Applied Biosystems) was used to acquire the data.
Figure 5. Schematic overview of the experimental strategy followed. A total of three replicates (with six 
mice each) were analysed to study the effect of different Ancylostoma caninum excretory/secretory (ES) protein 
doses in the intestine of mice with DSS-induced colitis (A). The protein changes of the lamina propria (LP) and 
intestinal epithelial cell layer (IEC) of mice with DSS-induced colitis treated with A. caninum ES proteins were 
analysed in duplicate (B).
www.nature.com/scientificreports/
9Scientific RepoRts | 7:41883 | DOI: 10.1038/srep41883
Bioinformatic analysis of proteomic sequence data. All MS/MS samples were analyzed using 
Mascot (Matrix Science, London, UK; version 2.5.1) and X! Tandem (The GPM, thegpm.org; version CYCLONE 
(2010.12.01.1)). Mascot was set up to search a subset of the Uniprot database containing proteins from Mus 
musculus assuming trypsin digestion. Parameters for Mascot and X! Tandem searches included a fragment ion 
mass tolerance of 0.60 Da and a parent ion tolerance of 0.60 Da and fixed modifications of O+  18 of pyrrolysine 
and iTRAQ8plex labelling of lysine and the n-terminus. In X! Tandem searches variable modifications specified 
were Glu-> pyro-Glu of the n-terminus, ammonia-loss of the n-terminus, Gln-> pyro-Glu of the n-terminus, oxi-
dation of methionine, methylthio of cysteine and iTRAQ8plex labelling of tyrosine. In Mascot searches variable 
modifications specified were oxidation of methionine, and iTRAQ8plex labelling of tyrosine. Scaffold Q+ (ver-
sion Scaffold_4.2.1) was used to validate MS/MS based peptide and protein identifications. Peptide and protein 
identifications were accepted if they could be established at greater than 95% and 99% probability, respectively, as 
specified by the Peptide Prophet algorithm57, and contained at least two identified peptides58. Proteins containing 
similar peptides that could not be differentiated based on MS/MS analysis were grouped to satisfy the principles 
of parsimony. A false discovery rate (FDR) of < 0.1%, < 2.1% and < 2.8% for proteins from samples GS, LP and 
IEC layer was calculated using protein identifications validated by the Scaffold Q+ program.
Scaffold Q+ was used to quantify the isobaric tag peptide and protein identifications. Channels were corrected 
in all samples according to the algorithm described in i-Tracker59 and acquired intensities in the experiment 
were globally normalized across all acquisition runs. Individual quantitative samples were normalized within 
each acquisition run, and intensities for each peptide identification were normalized within the assigned pro-
teins. The reference channels were normalized to produce a 1:1 fold change. All normalization calculations were 
performed using medians to multiplicatively normalize data. Differentially expressed proteins were determined 
using Kruskal-Wallis Test analysis and results expressed in log2 ratios. Only proteins with a P-value < 0.05 were 
taken in consideration for further analysis. Blast2GO60 was used to classify proteins according to gene ontol-
ogy (GO) categories, and Pfam analysis was performed using HMMER v3.1b1 (http://hmmer.org/). Plots were 
generated using Multiplot Studio v1.5.20. The mass spectrometry proteomics data have been deposited in the 
ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org) via the PRIDE partner reposi-
tory61 with the dataset identifier PXD004369.
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